APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amrinone for Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amrinone for Injection Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchAmrinone for Injection Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Amrinone for Injection Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Amrinone for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amrinone for Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Amrinone for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Amrinone for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amrinone for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amrinone for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amrinone for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amrinone for Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amrinone for Injection market include Qilu Pharmaceutical Co., Ltd., Hainan Huanglong Pharmaceutical Co., Ltd. and Dandong Yichuang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amrinone for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amrinone for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amrinone for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amrinone for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Amrinone for Injection Segment by Company

Qilu Pharmaceutical Co., Ltd.

Hainan Huanglong Pharmaceutical Co., Ltd.

Dandong Yichuang Pharmaceutical Co., Ltd.

Amrinone for Injection Segment by Type

50mg

100mg

Amrinone for Injection Segment by Application

Hospital

Clinic

Other

Amrinone for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amrinone for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amrinone for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amrinone for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Amrinone for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amrinone for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amrinone for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amrinone for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amrinone for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amrinone for Injection industry.

Chapter 3: Detailed analysis of Amrinone for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amrinone for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amrinone for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amrinone for Injection Industry Trends Table 2. Amrinone for Injection Industry Drivers Table 3. Amrinone for Injection Industry Opportunities and Challenges Table 4. Amrinone for Injection Industry Restraints Table 5. Global Amrinone for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amrinone for Injection Revenue Share by Company (2021-2026) Table 7. Global Amrinone for Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Amrinone for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Amrinone for Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Amrinone for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amrinone for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Amrinone for Injection Company, Product Type & Application Table 13. Global Amrinone for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amrinone for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg Table 18. Significant Companies of 100mg Table 19. Global Amrinone for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Amrinone for Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Amrinone for Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Amrinone for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Amrinone for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Amrinone for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Amrinone for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Amrinone for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Amrinone for Injection Sales Value Share by Type (2021-2026) Table 28. Global Amrinone for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Amrinone for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Amrinone for Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Amrinone for Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Amrinone for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Amrinone for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Amrinone for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Amrinone for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Amrinone for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Amrinone for Injection Sales Value Share by Application (2021-2026) Table 41. Global Amrinone for Injection Sales Value Share by Application (2027-2032) Table 42. Global Amrinone for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Amrinone for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Amrinone for Injection Sales Market Share by Region (2021-2026) Table 45. Global Amrinone for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Amrinone for Injection Sales Market Share by Region (2027-2032) Table 47. Global Amrinone for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Amrinone for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Amrinone for Injection Sales Value Share by Region (2021-2026) Table 50. Global Amrinone for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Amrinone for Injection Sales Value Share by Region (2027-2032) Table 52. Global Amrinone for Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Amrinone for Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Amrinone for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Amrinone for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Amrinone for Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Amrinone for Injection Sales Market Share by Country (2021-2026) Table 58. Global Amrinone for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Amrinone for Injection Sales Market Share by Country (2027-2032) Table 60. Global Amrinone for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Amrinone for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Amrinone for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Amrinone for Injection Sales Value Market Share by Country (2027-2032) Table 64. Qilu Pharmaceutical Co., Ltd. Company Information Table 65. Qilu Pharmaceutical Co., Ltd. Business Overview Table 66. Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 68. Qilu Pharmaceutical Co., Ltd. Recent Development Table 69. Hainan Huanglong Pharmaceutical Co., Ltd. Company Information Table 70. Hainan Huanglong Pharmaceutical Co., Ltd. Business Overview Table 71. Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 73. Hainan Huanglong Pharmaceutical Co., Ltd. Recent Development Table 74. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information Table 75. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview Table 76. Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio Table 78. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Amrinone for Injection Distributors List Table 82. Amrinone for Injection Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Amrinone for Injection Product Image Figure 2. Global Amrinone for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amrinone for Injection Sales (2021-2032) & (K Units) Figure 5. Global Amrinone for Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Amrinone for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg Image Figure 10. 100mg Image Figure 11. Global Amrinone for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Amrinone for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Amrinone for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Amrinone for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Amrinone for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Amrinone for Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Amrinone for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Amrinone for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Amrinone for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Amrinone for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Amrinone for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Amrinone for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Amrinone for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Amrinone for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Amrinone for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Amrinone for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Amrinone for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Amrinone for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Amrinone for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Amrinone for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Amrinone for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Amrinone for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Amrinone for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Amrinone for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Amrinone for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Amrinone for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Amrinone for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Qilu Pharmaceutical Co., Ltd.
  • Hainan Huanglong Pharmaceutical Co., Ltd.
  • Dandong Yichuang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amrinone for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Amrinone for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Amrinone for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amrinone for Injection Market Dynamics
  1. 2.1 Amrinone for Injection Industry Trends
  2. 2.2 Amrinone for Injection Industry Drivers
  3. 2.3 Amrinone for Injection Industry Opportunities and Challenges
  4. 2.4 Amrinone for Injection Industry Restraints
3 Amrinone for Injection Market by Company
  1. 3.1 Global Amrinone for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Amrinone for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Amrinone for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Amrinone for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Amrinone for Injection Company Ranking (2024-2026)
  6. 3.6 Global Amrinone for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Amrinone for Injection Company Product Type and Application
  8. 3.8 Global Amrinone for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amrinone for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amrinone for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amrinone for Injection Market by Type
  1. 4.1 Amrinone for Injection Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.2 Global Amrinone for Injection Sales Volume by Type
  5. 4.2.1 Global Amrinone for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amrinone for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Amrinone for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Amrinone for Injection Sales Value by Type
  9. 4.3.1 Global Amrinone for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amrinone for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Amrinone for Injection Sales Value Share by Type (2021-2032)
5 Amrinone for Injection Market by Application
  1. 5.1 Amrinone for Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Amrinone for Injection Sales Volume by Application
  6. 5.2.1 Global Amrinone for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amrinone for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Amrinone for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Amrinone for Injection Sales Value by Application
  10. 5.3.1 Global Amrinone for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amrinone for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Amrinone for Injection Sales Value Share by Application (2021-2032)
6 Amrinone for Injection Regional Sales and Value Analysis
  1. 6.1 Global Amrinone for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amrinone for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Amrinone for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Amrinone for Injection Sales by Region (2027-2032)
  5. 6.3 Global Amrinone for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amrinone for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amrinone for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amrinone for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Amrinone for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amrinone for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Amrinone for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amrinone for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Amrinone for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amrinone for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amrinone for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amrinone for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Amrinone for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amrinone for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amrinone for Injection Sales Value Share by Country, 2025 VS 2032
7 Amrinone for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Amrinone for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amrinone for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amrinone for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Amrinone for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Amrinone for Injection Sales by Country (2027-2032)
  6. 7.4 Global Amrinone for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amrinone for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amrinone for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amrinone for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amrinone for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amrinone for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amrinone for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amrinone for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amrinone for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amrinone for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amrinone for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amrinone for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amrinone for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amrinone for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amrinone for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amrinone for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amrinone for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amrinone for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amrinone for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amrinone for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amrinone for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amrinone for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amrinone for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amrinone for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amrinone for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amrinone for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amrinone for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amrinone for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amrinone for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amrinone for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amrinone for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amrinone for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amrinone for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharmaceutical Co., Ltd.
  2. 8.1.1 Qilu Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  6. 8.1.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Hainan Huanglong Pharmaceutical Co., Ltd.
  8. 8.2.1 Hainan Huanglong Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Hainan Huanglong Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hainan Huanglong Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  12. 8.2.5 Hainan Huanglong Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Dandong Yichuang Pharmaceutical Co., Ltd.
  14. 8.3.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dandong Yichuang Pharmaceutical Co., Ltd. Amrinone for Injection Product Portfolio
  18. 8.3.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amrinone for Injection Value Chain Analysis
  2. 9.1.1 Amrinone for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amrinone for Injection Sales Mode & Process
  6. 9.2 Amrinone for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amrinone for Injection Distributors
  9. 9.2.3 Amrinone for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst